ReviewPharmaceutics2022

Nanocarriers as a Delivery Platform for Anticancer Treatment: Biological Limits and Perspectives in B-Cell Malignancies.

Sara Bozzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.